Beyfortus Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Nirsevimab

Indications/Uses

Prevention of resp syncytial virus (RSV) lower resp tract disease in neonates & infants during their 1st RSV season.

Dosage/Direction for Use

IM Infant weighing ≥5 kg 100 mg as single dose, <5 kg 50 mg as single dose. Administer prior to RSV season commencement or from birth for infants born during RSV season.

Contraindications

Hypersensitivity.

MIMS Class

Antivirals

ATC Classification

J06BD08 - nirsevimab ; Belongs to the class of antiviral monoclonal antibodies. Used in passive immunizations.

Regulatory Classification

POM

Presentation/Packing

Form

Beyfortus soln for inj 100 mg/mL

Packing/Price

1's

Form

Beyfortus soln for inj 50 mg/0.5 mL

Packing/Price

1's

Beyfortus

Manufacturer:

Patheon Manufacturing Services LLC